ClinicalTrials.Veeva

Menu

Pattern and Management of Intracranial Cavernoma

A

Assiut University

Status

Unknown

Conditions

Management of Intracranial Cavernous Hemangioma

Treatments

Procedure: surgical excision of intracranial cavernoma

Study type

Observational

Funder types

Other

Identifiers

NCT04181086
intracranial cavernoma

Details and patient eligibility

About

Intracranial cavernous vascular malformations are variously known as cavernous angiomas, cavernous hemangiomas, or, more simply, cavernomas. Cavernomas are congenital low flow vascular lesions. It composed of irregular sinusoidal vascular channels, lacking smooth muscle, and elastic fibers. They lack feeding arteries or draining veins and contain no neural tissue. The first description of an intracranial cavernoma was given by Virchow, in 1863. For over a century, it was considered to be an extremely rare malformation, usually found at autopsy, and exceptionally diagnosed during life. The prevalence of cerebral cavernous malformations (CCM) is estimated to be 0.4-0.9%.

Enrollment

35 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients presented with intracranial cavernomas (single or multiple, superficial or deep, supratentorial or infratentorial)
  • Denovo or recurrent patients.

Exclusion criteria

  • None

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems